IGF::OT::IGF R&D Quality Control of Electronic Pathology (E-Path) results (Stage Appropriate Cases) Period of Performance 09/12/14 - 09/11/15
IGF::OT::IGF R&D Quality Control of Electronic Pathology (E-Path) results (Stage Appropriate Cases) Period of Performance 09/12/14 - 09/11/15
批准号:
8947589
负责人:
CHRISTINA CLARKE, PH.D.
金额:
$10.2万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-12 至 2015-09-11
关键词:
AddendumAdherenceAgeAge FactorsCharacteristicsColon CarcinomaColorectal CancerDatabasesDiagnosisElectronicsGoldGuidelinesHead and Neck CancerHospitalsHuman PapillomavirusInsuranceKRAS2 geneMalignant NeoplasmsMolecularMutationNCI-Designated Cancer CenterNational Comprehensive Cancer NetworkPathologyPathology ReportPatientsPerformancePhysiciansPovertyPrevalencePublic HospitalsQuality ControlRaceRecordsRegistriesStagingTeaching HospitalsTest ResultTestingViralcohortinterestmedical specialtiesquality assuranceresearch and development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CPIC will assess quality and completeness of electronic pathology (E-Path) results for colorectal cancer and head and neck cancer. CPIC will collect electronic pathology results for KRAS mutation test results from colorectal cancer case records, and will collect human papilloma virus (HPV) results from head and neck cancer case records. CPIC will assess the completeness of these records and document compliance with recommended testing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金